US Injectable Compounding Pharmacy Market To Witness Significant Growth Due To R&D in Injectable Drugs
Compounding pharmacy involves combining or mixes of APIs to develop a customized drug for various diseases. An injectable compounded medication is a sterile drug to be administered into the body using a needle and syringe or an I.V. administration set and needle device. The U.S. injectable compounding pharmacy market is driven by R&D in injectable drugs. For instance, November 2020, Paradigm Biopharmaceuticals Ltd. initiated a Phase II clinical trial of subcutaneous injectable Pentosan Polysulphate Sodium (iPPS), in patients with the ultra-rare orphan disease Mucopolysaccharidosis Type 1 (MPS-1). One of the most common compounded injectable medications used in the U.S. injectable compounding pharmacy market include, Acetylcysteine 100 mg/mL, Acetyl-L-Carnitine 200 mg/mL, Amino Acid, Arginine HCL, Arginine HCL, Biotin, Carnitine, and Chromium. Acetyl-L-carnitineis an acetylated form of L-carnitine. It is naturally produced by the human body, and it is available as a dietar...